MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
IQVIA Holdings EBITDA per Share 2011-2026 | IQV
Annual EBITDA per Share IQVIA Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.4 | 18.3 | 16.9 | 15.6 | 13.9 | 10.6 | 10.5 | 9.57 | 8.42 | 7.49 | 6.56 | 5.63 | 4.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.4 | 4.7 | 11.3 |
Quarterly EBITDA per Share IQVIA Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.55 | 4.33 | - | 4.55 | 4.33 | 4.23 | - | 4.25 | 4.25 | 3.9 | - | 3.86 | 3.84 | 3.95 | - | 3.33 | 3.28 | 3.47 | 1.51 | 2.65 | 1.94 | 2.66 | 0.86 | 2.59 | 2.5 | 2.56 | 1.05 | 2.29 | 2.2 | 2.24 | - | 2.1 | 1.7 | 1.89 | 0.58 | 1.7 | 1.53 | 1.77 | 1.49 | 1.62 | 1.53 | 1.39 | 1.28 | 1.41 | 1.32 | 1.31 | 0.98 | 1.18 | 0.98 | 1.21 | 0.82 | 1.17 | 1.08 | 1 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.55 | 0.58 | 2.29 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.2 | 2.24 % | $ 168 M |  China |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 115.31 | 0.22 % | $ 35.1 B |  USA |
 |
BioNano Genomics
BNGO
|
-4.37 | $ 1.13 | - | $ 6.15 M | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 16.27 | 1.37 % | $ 867 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 500.74 | 1.46 % | $ 14.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.44 | 2.07 % | $ 411 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
NeoGenomics
NEO
|
-0.62 | $ 7.92 | 2.99 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.39 | 1.46 % | $ 1.85 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 23.13 | - | $ 642 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.66 | -0.3 % | $ 278 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 175.83 | 0.1 % | $ 8.71 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.54 | -0.17 % | $ 2.67 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 191.02 | 0.74 % | $ 136 B | USA |
 |
Neuronetics
STIM
|
-0.42 | $ 1.35 | - | $ 89 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 123.13 | 1.82 % | $ 19.6 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 14.96 | 3.67 % | $ 452 M | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 501.62 | 1.11 % | $ 189 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.08 | $ 0.68 | -4.69 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
-3.17 | $ 79.09 | 0.62 % | $ 9.92 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 49.04 | 2.36 % | $ 2.93 B | USA |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.74 | 1.86 % | $ 88.9 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.07 | -2.73 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.28 | -0.11 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 108.74 | 1.53 % | $ 8.97 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 261.85 | 0.35 % | $ 21.8 B | USA |
 |
Natera
NTRA
|
-5.33 | $ 201.35 | 4.31 % | $ 19.8 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 120.37 | 2.75 % | $ 5.63 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 81.02 | 0.53 % | $ 5.47 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 318.49 | -0.47 % | $ 19 B | USA |